Doxorubicin (Adriamycin) is a chemotherapy medication that’s used to treat many types of cancer. They can include ovarian cancer, breast cancer, and soft tissue sarcoma, among others. It’s an intravenous (IV) infusion that's given at a medical office or clinic, usually once every 3 or 4 weeks. Sometimes, it’s used alone. But other times, it’s given with other cancer medications. Doxorubicin (Adriamycin) can cause side effects like nausea, hair loss, and low blood cell counts. Like other medications in the anthracycline group, doxorubicin (Adriamycin) also has a risk of heart problems.
Certain bladder cancers
Wilms’ tumor (a type of kidney cancer in children)
Doxorubicin (Adriamycin) is a chemotherapy medication known as an anthracycline. It works by damaging the DNA in the cells in the body that grow very fast, including cancer cells. Cancer cells with damaged DNA can’t grow or spread as well. This helps treat cancer.
Source: DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Less common
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:
Fast or irregular heartbeat
shortness of breath
swelling of the feet and lower legs
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Recommended for many different cancers, based on guidelines from the National Comprehensive Cancer Network
Typically given once every 3 to 4 weeks
Each infusion usually only takes 10 to 15 minutes
Commonly causes nausea and hair loss
Can raise the risk of serious heart problems
Will need to do lab work and echocardiograms often to check for side effects
Be aware of how you feel during the doxorubicin (Adriamycin) infusion. Tell the nurse right away if the skin around your IV hurts, burns, or feels warm. This can be a sign that the medication has leaked from the vein, which can sometimes damage the tissue around it. The nurse can help manage this side effect.
Doxorubicin (Adriamycin) often causes nausea and vomiting. Your oncologist will give you antiemetics like ondansetron (Zofran) or prochlorperazine to take at home between your infusions if you need them. Call your oncology care team if the nausea or vomiting gets too strong.
You might get sick more easily while you’re getting treated with doxorubicin (Adriamycin). It can also be hard for your body to fight infections. This is because the medication can cause low white blood cell counts. Try to avoid getting sick by washing your hands often, staying away from crowds, and washing raw fruits and vegetables well before eating them.
Check your temperature regularly, for example once a day. Call your care team as soon as possible if your temperature is 100.4 degrees Fahrenheit or higher. This means that you have a fever, which can sometimes be the only sign that you’re sick.
Doxorubicin (Adriamycin) might affect your ability to have children in the future. Talk to your oncology care team about your options for preserving your fertility.
It’s possible for doxorubicin (Adriamycin) to pass into human milk. But because of the way doxorubicin (Adriamycin) works, it could harm a breastfeeding infant. Because of this, you shouldn’t breastfeed while taking doxorubicin (Adriamycin).
Doxorubicin (Adriamycin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Although rare, doxorubicin (Adriamycin) can leak into the tissues around the IV line. This can cause pain, a burning or stinging feeling, blistering, and damage to the skin or tissues around it.
Tell your nurse right away if you feel pain any pain, burning, or warmth during your doxorubicin (Adriamycin) infusion. They’ll need to stop the infusion and put an ice pack over the area.
Risk factors: History of heart failure | Radiation to the chest | Previous treatment with anthracycline chemotherapy | Treatment with other medications that can cause damage to the heart
Doxorubicin (Adriamycin) can cause serious heart problems, such as heart rhythm problems and heart failure. These heart problems can happen during treatment or up to several years after you finish treatment. Your oncologist will make sure you don’t go over the limit on how much doxorubicin (Adriamycin) you can take in your lifetime. This limit helps lower the risk of heart problems.
If you have heart issues, talk to your oncologist before starting doxorubicin (Adriamycin) to see if it’s safe for you. You’ll need a heart scan called an echocardiogram (ECHO). You’ll also periodically need these scans during treatment to check that it’s still safe.
Watch for signs of heart problems while taking doxorubicin (Adriamycin). Be aware of irregular heartbeat, shortness of breath, swelling in your ankles or feet, sudden weight gain, and dizziness. If these symptoms happen, you’ll probably have to stop doxorubicin (Adriamycin).
Risk factors: Previous chemotherapy | Previous radiation | 50 years or older
Although rare, some people who got doxorubicin (Adriamycin) have had other blood cancers later, like acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). If this happens, these cancers usually show up 1 to 3 years after treatment. Your oncologist will check for this using lab tests, even after you’ve finished taking doxorubicin (Adriamycin). Talk to your oncologist if you’re worried about this risk.
Doxorubicin (Adriamycin) can cause your blood cell count to drop. For example, you might have low white blood cells. This can put you at risk of infections that can be serious or make it harder to fight one off. Your white blood cell count usually hits its lowest about 2 weeks after each doxorubicin (Adriamycin) infusion. It usually bounces back up about a week later.
Doxorubicin (Adriamycin) can also cause low red blood cell counts. This can lead to anemia and make you feel tired. In addition, the medication can cause you to have less platelets in your blood and raise your risk for bleeding. Some people have needed transfusions when their blood cell counts got too low.
Your oncology team will check your blood cell counts before each doxorubicin (Adriamycin) infusion. Tell your care team if you have any unexpected bruising or bleeding. Also call them if you feel very tired or are getting sick often. These can be signs of low blood cell counts. If this happens, your oncologist might lower your dose or delay when you get the infusion.
People with liver problems can have a hard time getting rid of doxorubicin (Adriamycin) from their body. This is because the liver helps remove the medication after it works to fight cancer. With poor liver function, doxorubicin (Adriamycin) can build up in the body and raise the risk of harmful side effects.
Tell your oncologist if you have liver problems before starting doxorubicin (Adriamycin). They’ll check your liver with blood tests before and during treatment. If you have liver problems, you might need a lower dose of doxorubicin (Adriamycin) to prevent serious side effects. People with severe liver damage can’t take doxorubicin (Adriamycin) because it can be too dangerous.
Doxorubicin (Adriamycin) can cause a serious condition called tumor lysis syndrome (TLS) in people with fast-growing cancers. It can affect the electrolyte levels in the body. This can lead to muscle cramps, kidney problems, abnormal heart rhythms if not treated.
Call your oncology care team right away if you have nausea, vomiting, low appetite, side pain, dark urine, or less urination. Also call them if you have muscle cramps, numbness, or heart palpitations. These could be signs of TLS.
Risk factors: Previous radiation therapy
Tell your oncology care team if you’ve had radiation therapy before. Although uncommon, you might have a reaction called radiation recall while you’re taking doxorubicin (Adriamycin). This can cause a rash in the area where you had radiation. Let your care team know if you see a new or worse rash so they can help manage your symptoms.
Doxorubicin (Adriamycin) can make radiation side effects worse if the two therapies are given together. If your treatment includes both, talk to your oncology care team about the safest plan for you.
Risk factors: Pregnancy
Based on animal studies and the way the medication works, doxorubicin (Adriamycin) might raise the risk of harm to an unborn baby if it’s given during pregnancy.
Before starting doxorubicin (Adriamycin), talk to your oncologist about the risks and benefits of treatment and options for family planning. Let your oncology team know right away if you or your partner becomes pregnant while taking doxorubicin (Adriamycin).
Doxorubicin (Adriamycin) is given as an infusion through the vein (also called intravenous or IV). It’s given by a healthcare professional at a medical center or infusion clinic.
Your oncologist will calculate your dose of doxorubicin (Adriamycin) based on your body surface area (BSA), taking into account your height and weight.
The general dose range is between 40 mg/m2 and 75 mg/m2 given IV once every 3 to 4 weeks.
Note: The dose depends on the type of cancer you have. It also depends on whether you’re taking it by itself or with other medications to treat your cancer. The dose can also differ based on the treatment protocol that your oncologist is following.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Severe liver problems
Recent heart attack (within the past 4 to 6 weeks)
Serious heart problems
Severely low blood cell counts that don’t get better
Allergic reaction to another doxorubicin product, such as liposomal doxorubicin (Doxil)
Certain bladder cancers
Wilms’ tumor (a type of kidney cancer in children)
Remaining cancer in the armpit region (axillary node tumor) after removal of primary breast cancer tumor
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Cancer Society. (n.d.). Acute myeloid leukemia (AML) in adults.
American Cancer Society. (2018). What is acute lymphocytic leukemia (ALL)?
American Cancer Society. (2018). What is ovarian cancer?
American Cancer Society. (2021). Chemotherapy for breast cancer.
American Cancer Society. (2024). Fevers.
American Cancer Society. (2024). Mouth soreness and pain.
American Cancer Society. (2024). Neutropenia (low white blood cell counts).
American Cancer Society. (2024). Thrombocytopenia (low platelet count).
American Cancer Society. (2024). Treating classic Hodgkin lymphoma, by stage.
American Cancer Society. (2025). What are Wilms tumors?
Boschi, R., et al. (2012). Extravasation of antineoplastic agents: Prevention and treatments. Pediatric Reports.
Burris, H. A., 3rd, et al. (2010). Radiation recall with anticancer agents. The Oncologist.
Cancer for Disease Control and Prevention. (n.d.). What you need to know: Neutropenia and risk for infection.
Chatterjee, K., et al. (2009). Doxorubicin cardiomyopathy. Cardiology.
Eunice Kennedy Shriver National Institute of Child Health and Human Development. (2017). What is fertility preservation?
Gland Pharma Limited. (2024). Doxorubicin hydrochloride injection, solution [package insert]. DailyMed.
Gupta, A., et al. (2018). Tumor lysis syndrome. Journal of the American Medical Association Oncology.
Johnson-Arbor, K., et al. (2023). Doxorubicin. StatPearls.
National Cancer Institute. (n.d.). Anthracycline.
National Cancer Institute. (n.d.). Bone cancer–Patient version.
National Cancer Institute. (n.d.). Myelosuppression.
National Cancer Institute. (n.d.). Port.
National Cancer Institute. (n.d.). Soft tissue sarcoma–Patient version.
National Cancer Institute. (n.d.). Thyroid cancer–Patient version.
National Cancer Institute. (n.d.). What is stomach cancer?
National Cancer Institute. (2023). What is bladder cancer?
National Cancer Institute. (2024). Neuroblastoma lymphoma treatment (PDQ®) – Patient version.
National Cancer Institute. (2024). Non-Hodgkin lymphoma treatment (PDQ®) – Patient version.
National Cancer Institute. (2025). Hodgkin lymphoma treatment (PDQ®) – Patient version.
National Cancer Institute. (2025). Nausea and vomiting related to cancer treatment (PDQ®)–Health Professional Version.
National Comprehensive Cancer Network. (2022). Nausea and vomiting.
National Comprehensive Cancer Network. (2025). Anemia and neutropenia: Low blood cell counts.
Rheingold, S. R., et al. (2003). Therapy-related secondary cancers. Holland-Frei Cancer Medicine 6th edition.
Rossi, A., et al. (2017). Chemotherapy-induced alopecia management: Clinical experience and practical advice. Journal of Cosmetic Dermatology.
Venkatesh, P., et al. (2023). Anthracyclines. StatPearls.
Weberding, J. (2015). Outpatient oncology drug series: Doxorubicin is the infamous red devil. Oncology Nursing Society VOICE.
West, H. J. (2017). Chemotherapy-induced hair loss (alopecia). Journal of the American Medical Association Oncology.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.